My HPRA: Register

VAXZEVRIA/COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC as approved by the HPRA - Updated Information

Notice type: 3rd Party Publications

Date: 01/06/2021


Problem Or Issue:

Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC regarding VAXZEVRIA/COVID-19 Vaccine AstraZeneca: Risk of thrombosis in combination with thrombocytopenia – Updated information

 

Important Safety Information - VAXZEVRIA COVID-19 Vaccine AstraZeneca

« Back